$0.05
(1.82%)
| Today's Open | $2.97 |
|---|---|
| Previous Close | $2.72 |
| Daily Range | $2.64 - $3.06 |
| 52-Week Range | $1.60 - $4.93 |
| Market Cap | $233.1M |
| P/E Ratio | -6.18 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,832,612 |
| Average Daily Volume | 218,176 |
| Current FY EPS | -$0.35 |
Sector
Healthcare
Industry
Drugs
Oncolytics Biotech, Inc. (USA) (ONCY) Description
A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers. Website: http://www.oncolyticsbiotech.com/
News & Commentary
Oncolytics announces successful tests for cancer drug Reolysin.
Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.3 Potential Game-Changing Cancer Drugs
Find out which surprisingly strange cancer therapies could be on the way.ONCY's Top Competitors
(1.10%)
(0.28%)
(-0.96%)
(0.75%)